| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.64B | +29.4% |
| R&D Expense | $313.9M | +16.3% |
| SG&A Expense | $225.1M | +14.9% |
| Operating Income | $77.5M | +298.2% |
| Pre-tax Income | $71.6M | +336.8% |
| Income Tax | $3.7M | -45.1% |
| Net Income | $67.9M | +283.7% |
| EPS (Basic) | $0.33 | +273.7% |
| EPS (Diluted) | $0.31 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $542.4M | +47.4% |
| Current Assets | $1.32B | +46.6% |
| Total Assets | $1.46B | +44.0% |
| Current Liabilities | $399.1M | +21.3% |
| Long-term Debt | $155.0M | — |
| Total Liabilities | $589.9M | +69.8% |
| Stockholders' Equity | $868.8M | +30.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $325.1M | +67.2% |
| Capital Expenditures | $29.4M | +390.7% |
| Investing Cash Flow | -$69.9M | -295.1% |
| Financing Cash Flow | -$89.8M | +29.6% |
| Free Cash Flow | $295.7M | +56.9% |
| +263.2% |